SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-148022
Filing Date
2022-05-12
Accepted
2022-05-12 06:52:15
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d335958d10q.htm   iXBRL 10-Q 1678196
2 EX-31.1 d335958dex311.htm EX-31.1 11219
3 EX-31.2 d335958dex312.htm EX-31.2 11241
4 EX-32.1 d335958dex321.htm EX-32.1 3393
5 EX-32.2 d335958dex322.htm EX-32.2 3397
  Complete submission text file 0001193125-22-148022.txt   4523622

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20220331.xsd EX-101.SCH 26417
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nuvl-20220331_cal.xml EX-101.CAL 23741
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvl-20220331_def.xml EX-101.DEF 155850
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20220331_lab.xml EX-101.LAB 235714
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20220331_pre.xml EX-101.PRE 196225
44 EXTRACTED XBRL INSTANCE DOCUMENT d335958d10q_htm.xml XML 480404
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 22915624
SIC: 2834 Pharmaceutical Preparations